Evidence map›Paper›PMID 32161589›Full record

ArticleFrontiers in immunology2020

Characterization of a Cytomegalovirus-Specific T Lymphocyte Product Obtained Through a Rapid and Scalable Production Process for Use in Adoptive Immunotherapy.

Marta Grau-Vorster, María López-Montañés, Ester Cantó, Joaquim Vives, Irene Oliver-Vila, Pere Barba, Sergi Querol, Francesc Rudilla

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Marta Grau-VorsterCell Therapy Service, Banc de Sang i Teixits, Barcelona, Spain.
María López-MontañésCell Therapy Service, Banc de Sang i Teixits, Barcelona, Spain.
Ester CantóCell Therapy Service, Banc de Sang i Teixits, Barcelona, Spain.
Joaquim VivesCell Therapy Service, Banc de Sang i Teixits, Barcelona, Spain.
Irene Oliver-VilaCell Therapy Service, Banc de Sang i Teixits, Barcelona, Spain.
Pere BarbaHematology Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
Sergi QuerolCell Therapy Service, Banc de Sang i Teixits, Barcelona, Spain.
Francesc RudillaCell Therapy Service, Banc de Sang i Teixits, Barcelona, Spain.
Banc de Sang i Teixits · ESUniversitat Autònoma de Barcelona · ESVall d'Hebron Institut de Recerca · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immunosuppressed patients are susceptible to virus reactivation or

Indexed as

Antigens, Differentiation, T-LymphocyteCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCell Culture TechniquesCytokinesCytomegalovirusCytomegalovirus InfectionsDendritic CellsHealthy VolunteersHumansImmunotherapy, AdoptiveInterferon-gammaLeukocytes, MononuclearMonocytesT-Lymphocytes, CytotoxicViral Matrix ProteinsAntigens, Differentiation, T-LymphocyteCytokinescytomegalovirus matrix protein 65kDaInterferon-gammaViral Matrix Proteinsadoptive immunotherapyalloreactivityantigen presenting cells (APC)cytotoxicityperipheral blood mononuclear cells (PBMC)specificityvirus specific T lymphocytes (VST)

Identifiers

PMID32161589
PMCPMC7052482
OpenAlexW3007033760

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.